Skip to content

   Pharma Publications

Neuropsychopharmacology
  • Imaging brain energetics to advance metabolic psychiatry
    Published on 2025-12-26
    7 months ago
  • Identification of a stress-sensitive endogenous opioid-containing neuronal population in the paranigral ventral tegmental area
    Published on 2025-12-19
    7 months ago
  • In vivo evidence for metabotropic glutamate receptor 5 dysregulation in chronic pain
    Published on 2025-12-18
    7 months ago
  • Central amygdalar PKCδ neurons mediate fentanyl withdrawal
    Published on 2025-12-18
    7 months ago
  • ACNP 64th Annual Meeting: Poster Abstracts P292-583
    Published on 2025-12-17
    7 months ago
  • ACNP 64th Annual Meeting: Panels, Mini-Panels and Study Groups
    Published on 2025-12-17
    7 months ago
  • ACNP 64th Annual Meeting: Author Index
    Published on 2025-12-17
    7 months ago
« Previous 1 … 28 29 30 31 32 … 143 Next »
Journal of Psychopharmacology
  • Naturalistic use of psychedelics is associated with longitudinal improvements in anxiety and depression during global crisis times
    Published on 2025-06-18
    1 year ago
  • Uncertainty about lithium and suicide: A response to Nassir Ghaemi
    Published on 2025-06-17
    1 year ago
  • Dissecting the pro-neurogenic effects of monoaminergic medications used to treat depression: a systematic review and meta-analysis
    Published on 2025-06-11
    1 year ago
  • A model training curriculum for psychedelic, psycholytic, and entactogen-assisted psychotherapy
    Published on 2025-06-10
    1 year ago
  • Six weeks open-label oral ketamine for patients with treatment-resistant depression, post-traumatic stress disorder, or obsessive-compulsive disorder
    Published on 2025-06-05
    1 year ago
  • Effects of serotonergic psychedelics on synaptogenesis and immediate early genes expression – comparison with ketamine, fluoxetine and lithium
    Published on 2025-05-29
    1 year ago
  • What are set and setting: Reducing vagueness to improve research and clinical practice
    Published on 2025-05-26
    1 year ago
« Previous 1 … 28 29 30 31 32 … 150 Next »
European Neuropsychopharmacology
  • Negative Symptoms in Schizophrenia: The Placebo Effect as a Barrier to Drug Development?
    Published on 2025-04-11
    1 year ago
  • Frequency, correlates and outcomes of Benzodiazepine use during Cariprazine treatment: A pooled post-hoc analysis from four 6-week, placebo-controlled trials in patients with an acute exacerbation of schizophrenia
    Published on 2025-03-16
    1 year ago
  • Letter to the editor: Premature conclusions on antipsychotic continuation in environmentally conscious psychopharmacotherapy
    Published on 2025-03-13
    1 year ago
  • COSMIN systematic review and meta-analysis of the measurement properties of the PANSS-6
    Published on 2025-03-10
    1 year ago
  • Ketamine addiction in Europe: Any risks on the horizons?
    Published on 2025-03-10
    1 year ago
  • Muscarinic acetylcholine receptor agonists in bipolar disorder
    Published on 2025-03-09
    1 year ago
  • Extracellular vesicles in mood disorders: A systematic review of human studies
    Published on 2025-03-09
    1 year ago
« Previous 1 … 28 29 30 31 32 … 168 Next »

   Pharma Pub